BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12048155)

  • 1. Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions.
    Grujić M; Renko M
    Cancer Lett; 2002 Aug; 182(2):113-9. PubMed ID: 12048155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines.
    Sekine K; Fujii H; Abe F; Nishikawa K
    Int J Cancer; 2001 Nov; 94(4):485-91. PubMed ID: 11745433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminopeptidase inhibitors inhibit proliferation and induce apoptosis of K562 and STI571-resistant K562 cell lines through the MAPK and GSK-3beta pathways.
    Sawafuji K; Miyakawa Y; Weisberg E; Griffin JD; Ikeda Y; Kizaki M
    Leuk Lymphoma; 2003 Nov; 44(11):1987-96. PubMed ID: 14738154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells.
    Krige D; Needham LA; Bawden LJ; Flores N; Farmer H; Miles LE; Stone E; Callaghan J; Chandler S; Clark VL; Kirwin-Jones P; Legris V; Owen J; Patel T; Wood S; Box G; Laber D; Odedra R; Wright A; Wood LM; Eccles SA; Bone EA; Ayscough A; Drummond AH
    Cancer Res; 2008 Aug; 68(16):6669-79. PubMed ID: 18701491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent homophthalimide-type inhibitors of B16F10/L5 mouse melanoma cell invasion.
    Kagechika H; Komoda M; Fujimoto Y; Koiso Y; Takayama H; Kadoya S; Miyata K; Kato F; Kato M; Hashimoto Y
    Biol Pharm Bull; 1999 Sep; 22(9):1010-2. PubMed ID: 10513635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines.
    Sekine K; Fujii H; Abe F
    Leukemia; 1999 May; 13(5):729-34. PubMed ID: 10374877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
    Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
    Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin.
    Huo X; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Liu K
    Eur J Pharm Sci; 2013 Nov; 50(3-4):420-8. PubMed ID: 23981338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of extra- and intracellular alanyl aminopeptidases as new targets to modulate keratinocyte growth and differentiation.
    Thielitz A; Bukowska A; Wolke C; Vetter R; Lendeckel U; Wrenger S; Hashimoto Y; Ansorge S; Gollnick H; Reinhold D
    Biochem Biophys Res Commun; 2004 Sep; 321(4):795-801. PubMed ID: 15358097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bestatin, an inhibitor of aminopeptidase B, suppresses the proliferation and differentiation of human B-cells in vitro.
    Morikawa K; Morikawa S; Nakano A; Oseko F
    Int J Immunopharmacol; 1989; 11(8):905-13. PubMed ID: 2613395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin).
    Yoneda J; Saiki I; Fujii H; Abe F; Kojima Y; Azuma I
    Clin Exp Metastasis; 1992 Jan; 10(1):49-59. PubMed ID: 1733647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme.
    Tieku S; Hooper NM
    Biochem Pharmacol; 1992 Nov; 44(9):1725-30. PubMed ID: 1360211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of a membrane-bound enkephalin-degrading aminopeptidase by bestatin analogs.
    Shimamura M; Hazato T; Hachisu M; Katayama T
    J Neurochem; 1984 Sep; 43(3):888-90. PubMed ID: 6431055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase A.
    Ueda M; Ueki M; Fujii H; Yoshizawa K; Nakajima M
    J Med; 1997; 28(3-4):175-90. PubMed ID: 9355022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of sulfur-containing analogues of bestatin. Inhibition of aminopeptidases by alpha-thiolbestatin analogues.
    Ocain TD; Rich DH
    J Med Chem; 1988 Nov; 31(11):2193-9. PubMed ID: 3184126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminopeptidase inhibitor bestatin stimulates microvascular endothelial cell invasion in a fibrin matrix.
    van Hensbergen Y; Broxterman HJ; Peters E; Rana S; Elderkamp YW; van Hinsbergh VW; Koolwijk P
    Thromb Haemost; 2003 Nov; 90(5):921-9. PubMed ID: 14597989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
    Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the development of bestatin analogues as aminopeptidases inhibitors.
    Chen L; Teng Y; Xu W
    Curr Med Chem; 2011; 18(7):964-76. PubMed ID: 21254977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells.
    Mishima Y; Matsumoto-Mishima Y; Terui Y; Katsuyama M; Yamada M; Mori M; Ishizaka Y; Ikeda K; Watanabe J; Mizunuma N; Hayasawa H; Hatake K
    J Natl Cancer Inst; 2002 Jul; 94(13):1020-8. PubMed ID: 12096087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.
    Saiki I; Murata J; Watanabe K; Fujii H; Abe F; Azuma I
    Jpn J Cancer Res; 1989 Sep; 80(9):873-8. PubMed ID: 2513304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.